These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 21447485)
1. Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. Han MS; Lim YM; Quan W; Kim JR; Chung KW; Kang M; Kim S; Park SY; Han JS; Park SY; Cheon HG; Dal Rhee S; Park TS; Lee MS J Lipid Res; 2011 Jun; 52(6):1234-1246. PubMed ID: 21447485 [TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. Han MS; Park SY; Shinzawa K; Kim S; Chung KW; Lee JH; Kwon CH; Lee KW; Lee JH; Park CK; Chung WJ; Hwang JS; Yan JJ; Song DK; Tsujimoto Y; Lee MS J Lipid Res; 2008 Jan; 49(1):84-97. PubMed ID: 17951222 [TBL] [Abstract][Full Text] [Related]
3. The role of calcium-independent phospholipase A2γ in modulation of aqueous humor drainage and Ca2+ sensitization of trabecular meshwork contraction. Pattabiraman PP; Lih FB; Tomer KB; Rao PV Am J Physiol Cell Physiol; 2012 Apr; 302(7):C979-91. PubMed ID: 22237407 [TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial calcium-independent phospholipase A2γ (iPLA2γ) by divalent cations mediating arachidonate release and production of downstream eicosanoids. Moon SH; Jenkins CM; Liu X; Guan S; Mancuso DJ; Gross RW J Biol Chem; 2012 Apr; 287(18):14880-95. PubMed ID: 22389508 [TBL] [Abstract][Full Text] [Related]
5. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes. Vijayvargia R; Mann K; Weiss HR; Pownall HJ; Ruan H Obesity (Silver Spring); 2010 Sep; 18(9):1701-9. PubMed ID: 20094041 [TBL] [Abstract][Full Text] [Related]
6. Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling. Song H; Wohltmann M; Tan M; Bao S; Ladenson JH; Turk J J Biol Chem; 2012 Feb; 287(8):5528-41. PubMed ID: 22194610 [TBL] [Abstract][Full Text] [Related]
7. Suppression of Rho-kinase 1 is responsible for insulin regulation of the AMPK/SREBP-1c pathway in skeletal muscle cells exposed to palmitate. Tang S; Wu W; Tang W; Ge Z; Wang H; Hong T; Zhu D; Bi Y Acta Diabetol; 2017 Jul; 54(7):635-644. PubMed ID: 28265821 [TBL] [Abstract][Full Text] [Related]
8. Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK. Hitomi H; Mehta PK; Taniyama Y; Lassègue B; Seidel-Rogol B; San Martin A; Griendling KK Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1415-22. PubMed ID: 21900690 [TBL] [Abstract][Full Text] [Related]
9. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Prada PO; Zecchin HG; Gasparetti AL; Torsoni MA; Ueno M; Hirata AE; Corezola do Amaral ME; Höer NF; Boschero AC; Saad MJ Endocrinology; 2005 Mar; 146(3):1576-87. PubMed ID: 15591151 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin ameliorates PA-induced insulin resistance through the IRS/AKT/FOXO1 and GSK-3β signaling pathway, and inhibits the inflammatory response in HepG2 cells. Zhang H; Ge Z; Tang S; Meng R; Bi Y; Zhu D Mol Med Rep; 2017 Aug; 16(2):2295-2301. PubMed ID: 28656239 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcium-independent phospholipase A2 activates p38 MAPK signaling pathways during cytostasis in prostate cancer cells. Sun B; Zhang X; Yonz C; Cummings BS Biochem Pharmacol; 2010 Jun; 79(12):1727-35. PubMed ID: 20171194 [TBL] [Abstract][Full Text] [Related]
13. Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A2 (iPLA2beta ) indicate a signaling rather than a housekeeping role for iPLA2beta. Ma Z; Ramanadham S; Wohltmann M; Bohrer A; Hsu FF; Turk J J Biol Chem; 2001 Apr; 276(16):13198-208. PubMed ID: 11278673 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Gao Z; Zhang X; Zuberi A; Hwang D; Quon MJ; Lefevre M; Ye J Mol Endocrinol; 2004 Aug; 18(8):2024-34. PubMed ID: 15143153 [TBL] [Abstract][Full Text] [Related]
15. GVI phospholipase A2 role in the stimulatory effect of sphingosine-1-phosphate on TRPC5 cationic channels. AL-Shawaf E; Tumova S; Naylor J; Majeed Y; Li J; Beech DJ Cell Calcium; 2011 Oct; 50(4):343-50. PubMed ID: 21742378 [TBL] [Abstract][Full Text] [Related]
16. Induction of group VIA phospholipase A2 activity during in vitro ischemia in C2C12 myotubes is associated with changes in the level of its splice variants. Poulsen KA; Pedersen SF; Kolko M; Lambert IH Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1605-15. PubMed ID: 17804611 [TBL] [Abstract][Full Text] [Related]
17. Silibinin improves palmitate-induced insulin resistance in C2C12 myotubes by attenuating IRS-1/PI3K/Akt pathway inhibition. Li HB; Yang YR; Mo ZJ; Ding Y; Jiang WJ Braz J Med Biol Res; 2015 May; 48(5):440-6. PubMed ID: 25760026 [TBL] [Abstract][Full Text] [Related]
19. Cross-talk mechanisms in the development of insulin resistance of skeletal muscle cells palmitate rather than tumour necrosis factor inhibits insulin-dependent protein kinase B (PKB)/Akt stimulation and glucose uptake. Storz P; Döppler H; Wernig A; Pfizenmaier K; Müller G Eur J Biochem; 1999 Nov; 266(1):17-25. PubMed ID: 10542046 [TBL] [Abstract][Full Text] [Related]
20. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. Kang S; Chemaly ER; Hajjar RJ; Lebeche D J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]